logo

For the Inventor, By the Inventor

Brentford, United Kingdom

Beecham Group Plc


USPTO Granted Patents = 855

% Expired Patents = 0.23


Trademarks = 3

Forward Citations = 7,469

Loading Chart...
Loading Chart...

418 inventors (with patents filed for the assignee):

goldMedal Derek R Buckle (39 out of 42 patents)

silverMedal John P Clayton (37 out of 37 patents)

bronzeMedal Norman H Rogers (36 out of 36 patents)

4.  Harry Smith (34 out of 35 patents)

5.  Thomas T Howarth (33 out of 37 patents)

6.  John M Evans (33 out of 41 patents)

7.  Francis D King (31 out of 55 patents)

8.  Michael S Hadley (27 out of 33 patents)

9.  Frederick Cassidy (26 out of 26 patents)

10.  Roger J Ponsford (26 out of 26 patents)

11.  Richard M Hindley (25 out of 26 patents)

12.  Alexander C Goudie (25 out of 25 patents)

13.  Barrie C Cantello (25 out of 25 patents)

14.  Martin Cole (23 out of 27 patents)

15.  Gordon Wootton (20 out of 20 patents)


Core Competencies:
Beta-Lactam Antibiotics
Antiviral Compounds
Dementia Treatments
Pharmaceutical Compositions
Purine Derivatives
Xanthine Derivatives
Cephalosporin Derivatives
Hybrid Proteins
Aerosol Compositions
Heterocyclic Compounds
Azabicyclic Compounds
Antifungal Compounds

855 patents:

1. 6964865 - Host cells comprising Streptomyces clavuligerus chromosomal DNA fragments encoding enzymes for β-lactam antibiotic biosynthesis (2005-11-15),
2. 6709859 - Chromosomal DNA Fragments Encoding Enzymes for Encoding B-Lactam Biosynthesis Enzymes, and Vector and Transformants for Their Expression (2004-03-23),
3. 6686475 - Compounds (2004-02-03),
4. 6531600 - Treatment and compounds (2003-03-11),
5. 6288095 - Compounds (2001-09-11),
6. 6284736 - Amphotericin derivatives (2001-09-04),
7. 6258555 - DNA encoding ACV synthetase (2001-07-10),
8. 6180791 - Synthesis of 8-substituted xanthines (2001-01-30),
9. 6077536 - Pharmaceutical formulation (2000-06-20),
10. 6066468 - Chromosomal DNA fragments encoding enzymes for encoding .beta.-lactam (2000-05-23),
11. 6037156 - DNA molecules and vectors encoding clavulanic acid biosynthesis enzymes (2000-03-14),
12. 5981545 - N-linked azabicyclic heterocycles useful for treating dementia (1999-11-09),
13. 5814337 - Pharmaceutical formulation (1998-09-29),
14. 5792790 - Method for improving weight gain and feed utilization in livestock (1998-08-11),
15. 5759831 - DNA molecules and vectors regarding clavulanic acid biosynthesis enzymes (1998-06-02),
Beecham Group Plc, headquartered in Brentford, UK, specializes in the development and manufacturing of pharmaceutical formulations. The company focuses on a diverse range of therapeutic areas, including beta-lactam antibiotics, antiviral compounds, and treatments for dementia. Its expertise extends to pharmaceutical compositions involving purine and xanthine derivatives, as well as cephalosporin derivatives and hybrid proteins. Beecham Group is committed to advancing healthcare through innovative solutions in the pharmaceutical sector.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

855 Patents

#1 in Brentford

#13 in United Kingdom

#1,165 in the World

Brentford, GB
Brentford, United Kingdom

Beecham Group Plc

Forward Citations = 7,469

418 inventors:

goldMedal Derek R Buckle (39 out of 42 patents)

silverMedal John P Clayton (37 out of 37 patents)

bronzeMedal Norman H Rogers (36 out of 36 patents)

4.  Harry Smith (34 out of 35 patents)

5.  Thomas T Howarth (33 out of 37 patents)

Please report any incorrect information to [email protected]
Loading…